Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2004 Apr;13(2):119–121. doi: 10.1080/09679350410001688503

Effect of glucose concentration on peritoneal inflammatory cytokines in continuous ambulatory peritoneal dialysis patients.

Hayriye Sayarlioglu 1, Cevat Topal 1, Mehmet Sayarlioglu 1, Haluk Dulger 1, Ekrem Dogan 1, Reha Erkoc 1
PMCID: PMC1781549  PMID: 15203553

Abstract

OBJECTIVE: It is known that glucose concentrations of peritoneal dialysis solutions are detrimental to the peritoneal membrane. In order to determine the effect of glucose concentration on cytokine levels of peritoneal fluid of continuous ambulatory peritoneal dialysis (CAPD) patients, a cross-sectional study was performed. METHODS: Nine non-diabetic CAPD patients participated in two 8-h dwell sessions of overnight exchanges in consecutive days, with 1.36% and 3.86% glucose containing peritoneal dialysis solutions (Baxter-Eczacibas). Peritoneal dialysis fluid tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 levels were measured. RESULTS: TNF-alpha levels after 1.36% and 3.86% glucose used dwells were 23+/-14 pg/ml and 28+/-4 pg/ml, respectively (p=0.78). The IL-6 levels were 106+/-57 pg/ml and 115+/-63 pg/ml (p=0.81), respectively. CONCLUSION: In our in vivo study we found that the glucose concentration of the conventional lactate-based CAPD solution has no effect on basal IL-6 and TNF-alpha levels of peritoneal fluid. Further in vivo studies with non-lactate-based CAPD solutions are needed in order to determine the effect of glucose concentration per se on cytokine release.

Full Text

The Full Text of this article is available as a PDF (97.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alobaidi H. M., Coles G. A., Davies M., Lloyd D. Host defence in continuous ambulatory peritoneal dialysis: the effect of the dialysate on phagocyte function. Nephrol Dial Transplant. 1986;1(1):16–21. [PubMed] [Google Scholar]
  2. Cendoroglo M., Sundaram S., Jaber B. L., Pereira B. J. Effect of glucose concentration, osmolality, and sterilization process of peritoneal dialysis fluids on cytokine production by peripheral blood mononuclear cells and polymorphonuclear cell functions in vitro. Am J Kidney Dis. 1998 Feb;31(2):273–282. doi: 10.1053/ajkd.1998.v31.pm9469498. [DOI] [PubMed] [Google Scholar]
  3. Chan Tak-Mao, Leung Jack Kok-Hung, Sun Yuling, Lai Kar-Neng, Tsang Ryan Chi-Wai, Yung Susan. Different effects of amino acid-based and glucose-based dialysate from peritoneal dialysis patients on mesothelial cell ultrastructure and function. Nephrol Dial Transplant. 2003 Jun;18(6):1086–1094. doi: 10.1093/ndt/gfg096. [DOI] [PubMed] [Google Scholar]
  4. Douvdevani A., Rapoport J., Konforti A., Zlotnik M., Chaimovitz C. The effect of peritoneal dialysis fluid on the release of IL-1 beta and TNF alpha by macrophages/monocytes. Perit Dial Int. 1993;13(2):112–117. [PubMed] [Google Scholar]
  5. Goldman M., Vandenabeele P., Moulart J., Amraoui Z., Abramowicz D., Nortier J., Vanherweghem J. L., Fiers W. Intraperitoneal secretion of interleukin-6 during continuous ambulatory peritoneal dialysis. Nephron. 1990;56(3):277–280. doi: 10.1159/000186154. [DOI] [PubMed] [Google Scholar]
  6. Ha H., Yu M. R., Lee H. B. High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int. 2001 Feb;59(2):463–470. doi: 10.1046/j.1523-1755.2001.059002463.x. [DOI] [PubMed] [Google Scholar]
  7. Honda K., Nitta K., Horita S., Yumura W., Nihei H. Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron. 1996;72(2):171–176. doi: 10.1159/000188837. [DOI] [PubMed] [Google Scholar]
  8. Jörres A., Gahl G. M., Topley N., Neubauer A., Ludat K., Müller C., Passlick-Deetjen J. In-vitro biocompatibility of alternative CAPD fluids; comparison of bicarbonate-buffered and glucose-polymer-based solutions. Nephrol Dial Transplant. 1994;9(7):785–790. [PubMed] [Google Scholar]
  9. Liberek T., Topley N., Jörres A., Coles G. A., Gahl G. M., Williams J. D. Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration. J Am Soc Nephrol. 1993 Feb;3(8):1508–1515. doi: 10.1681/ASN.V381508. [DOI] [PubMed] [Google Scholar]
  10. Plum J., Fusshöller A., Schoenicke G., Busch T., Erren C., Fieseler C., Kirchgessner J., Passlick-Deetjen J., Grabensee B. In vivo and in vitro effects of amino-acid-based and bicarbonate-buffered peritoneal dialysis solutions with regard to peritoneal transport and cytokines/prostanoids dialysate concentrations. Nephrol Dial Transplant. 1997 Aug;12(8):1652–1660. doi: 10.1093/ndt/12.8.1652. [DOI] [PubMed] [Google Scholar]
  11. Serre A. F., Marie C., Beaujon G., Betail G., Cavaillon J. M., Deteix P. Variations of cytokine levels and production in CAPD patients. Int J Artif Organs. 1997 Nov;20(11):614–621. [PubMed] [Google Scholar]
  12. Topley N., Kaur D., Petersen M. M., Jörres A., Passlick-Deetjen J., Coles G. A., Williams J. D. Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: influence on mesothelial cell and neutrophil function. Kidney Int. 1996 May;49(5):1447–1456. doi: 10.1038/ki.1996.204. [DOI] [PubMed] [Google Scholar]
  13. Witowski J., Wisniewska J., Korybalska K., Bender T. O., Breborowicz A., Gahl G. M., Frei U., Passlick-Deetjen J., Jörres A. Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol. 2001 Nov;12(11):2434–2441. doi: 10.1681/ASN.V12112434. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES